CJC-1295 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
| Property | Value | Notes |
|---|---|---|
| Duration with linker | Several days | Reported in early human work |
| Duration without linker | Tens of minutes | Short plasma residence |
| Albumin attachment site | Cysteine-34 | Covalent maleimide reaction |
| Primary receptor | Pituitary GHRH receptor | Stimulates growth hormone release |
| Downstream marker | Insulin-like growth factor 1 | Indirect measure of activity |
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Comparative bullet-lead analysis was used by the FBI for over four decades, starting with the John F. Kennedy assassination in 1963. The theory was that each batch of ammunition possessed a chemical makeup so distinct that a bullet could be traced back to a particular batch or even a specific box. Internal studies and an outside study by the National Academy of Sciences found that the technique was unreliable due to improper interpretation, and the FBI abandoned the test in 2005. Forensic dentistry has come under fire: in at least three cases bite-mark evidence has been used to convict people of murder who were later freed by DNA evidence. A 1999 study by a member of the American Board of Forensic Odontology found a 63 percent rate of false identifications and is commonly referenced within online news stories and conspiracy websites. The study was based on an informal workshop during an ABFO meeting, which many members did not consider a valid scientific setting. The theory is that each person has a unique and distinctive set of teeth, which leave a pattern after biting someone. They analyze the dental characteristics such as size, shape, and arch form. Police Access to Genetic Genealogy Databases: There are privacy concerns with the police being able to access personal genetic data that is on genealogy services. Individuals can become criminal informants to their own families or to themselves simply by participating in genetic genealogy databases.
== See also == Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate Estradiol diundecylate/hydroxyprogesterone heptanoate/testosterone cyclohexylpropionate Estrapronicate/hydroxyprogesterone heptanoate/nandrolone undecanoate Progesterone/hydroxyprogesterone heptanoate/α-tocopherol palmitate
Management of radioactive waste and its safe and secure disposal is a necessary step in the lifecycle of all applications of nuclear science and technology (nuclear energy, research, industry, education, medical, and others). Radioactive waste is therefore generated in practically every country, the largest contribution coming from the nuclear energy lifecycle in countries operating nuclear power plants. Presently, there is broad scientific and technical consensus that disposal of high-level, long-lived radioactive waste in deep geologic formations is, at the state of today’s knowledge, considered as an appropriate and safe means of isolating it from the biosphere for very long time scales.
== Engineering and computer science == Renewable energy target Renewable energy technology Resolution enhancement technology, image processing technology used to manipulate dot characteristics ret, return from subroutine instruction in the x86 assembly language Registered engineering technologist, former certification in Alberta, Canada Rehabilitation engineering technologist, a role in rehabilitation engineering Ret, a measurement of the resistance to evaporative heat loss
=== Oral health === Many studies have shown the pro-inflammatory effect of nicotine on oral diseases. Nicotine promotes and aggravates some diseases such as periodontitis and gingivitis, especially when there are harmful microorganisms in the oral cavity, however, the data is insufficient, especially in vivo. Understanding the potential role of nicotine in oral health has become increasingly important given the recent introduction of novel nicotine products.
Sources: en.wikipedia.org
== History == In the fifth century BC, Hippocrates was the first to describe necrotizing soft tissue infections."Erysipelas all over the body while the cause was only a trivial accident. Bones, flesh, and sinew (cord, tendon, or nerve) would fall off from the body, and there were many deaths". Necrotizing soft-tissue infections were first described in English by British surgeon Leonard Gillespie and British physicians Gilbert Blaine and Thomas Trotter in the 18th century. At that time, there was no standardized name for NSTIs. They were variably described as severe ulcers, gangrene, erysipelas, or cellulitis. Later, "hospital gangrene" became more commonly used. In 1871, Confederate States Army surgeon Joseph Jones reported 2,642 cases of hospital gangrene with a mortality rate of 46%. In 1883, Dr Jean-Alfred Fournier described necrotizing infections of the perineum and scrotum, now named after him as Fournier gangrene. The term "necrotizing fasciitis" was coined by Dr. Bob Wilson in 1952. Since then, its definition has broadened to include infections of fascia and soft tissue. Despite being disfavored by the medical community, the term "galloping gangrene" was frequently used in sensationalistic news media to refer to outbreaks of necrotizing fasciitis. It is sometimes confused for eripheral symmetrical gangrene and acute rhabdomyolysis, and all three are sometimes incorrectly referred to as "flesh-eating virus".
The Fisher King (French: Roi Pêcheur) is a figure in the Arthurian legend, the last in a long line of British kings tasked with guarding the Holy Grail. The Fisher King is both the protector and physical embodiment of his lands, but a wound renders him impotent and his kingdom barren. Unable to walk or ride a horse, he is sometimes depicted as spending his time fishing while he awaits a hero who can heal him. Versions of the Grail King story vary widely, but the Fisher King, or the Maimed King (Roi Méhaigné), is typically depicted as being wounded in the groin, legs, or thigh. The healing of these wounds always depends upon the completion of a hero-knight's task. Besides the Holy Grail, the Lance of Longinus may feature as a key plot element. In some variants, a third character is introduced; this individual, unlike the hero-knight archetype, is ignorant of the King's power, but has the ability to save the king and land, or to doom it. As a literary character, the Fisher King originates in Chrétien de Troyes' unfinished writings of the adventures of the Grail Knight, Perceval. Many authors have endeavoured to complete and extend the work, resulting in various continuations. Major sources of the legend include Chrétien's Li Contes del Graal; Perceval, ou Le Conte du Graal (c. 1180–1190), Wauchier de Denain's First Continuation (c. 1190–1200), Robert de Boron's Didot-Perceval (c. 1191–1202), Peredur son of Efrawg (c. 1200), Perlesvaus (c. 1200), Wolfram von Eschenbach's Parzival (c. 1205), and Thomas Malory's Morte D'Arthur (c. 1400).
Researchers were able to identify differences in acacia and polyfloral honeys by the differing proportions of fructose and sucrose, as well as differing levels of aromatic amino acids phenylalanine and tyrosine. This ability allows greater ease of selecting compatible stocks.
Morris Carstairs, in a report on culture and personality study, stated that Indian men who are seemingly healthy are preoccupied with real or imagined spermatorrhea, with the belief that semen is not easily formed and "it takes 40 days, and 40 drops of blood, to make one drop of semen". He observed that when sexual behaviours are restricted, sexual incontinence follows with resultant guilt. In females, the corresponding fear of loss of sexual fluids is found in anxieties over vaginal discharge (sravam), which is believed to be a cooling body lubricant but whose loss leaves them "overheated and disarticulated, in a state of disease." Anxiety about loss of sexual fluids is caused from a misdiagnosis of sexual guilt, instead of correcting the psyche of a person the focus is shifted onto the substance (semen, sravam), resulting in subsequent pathologization. In Ayurveda, the term generally used for both male semen and female egg cell is Shukra. People with healthy shukra appear stronger and confident, with eyes and skin that seem lustrous. Those who lack higher shukra appear exhausted and lackluster, while also struggling in creative endeavours. Drinking lots of water and proper digestion of highly nourishing foods (milk, ghee, nuts) yield healthy shukra. Charaka states brahmacharya (abstinence), proper diet, and rest/sleep as the three pillars of life.
Sources: en.wikipedia.org
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.
The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.
Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.